Affibody Medical Investor Relations
Categories:
Navigation:
Non-Regulatory
February 19, 2010
Year-End Report 2009
Affibody Holding AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique...
Read more
December 1, 2009
Interim Report – January to September
Interim Report – January to September 2009 Affibody Holding AB (“Affibody” or “the Company”), a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and...
August 26, 2009
Interim Report – January to June 2009
April 29, 2009
Affibody – Interim Report – January to March 2009
March 24, 2009
Biovitrum gets access to Affibody® Technology
Affibody AB today signed a collaboration agreement with Biovitrum AB (publ) (STO:BVT) with the aim of developing new targeted therapeutics for inflammation and autoimmune diseases.
February 23, 2009
Year-End Report 2008
Affibody Holding AB (publ) (“Affibody” or “the Company”) today issued its year-end 2008 report. Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic...
December 14, 2008
Affibody appoints David Bejker as CEO
The Swedish biotech company Affibody Holding AB (“Affibody”) has appointed David Bejker as CEO.
March 27, 2008
Affibody: Unexpected Discovery Made by Swedish Researchers within the Field of Alzheimer: Newly Discovered Protein Inhibits the Formation of the Precursor to Alzheimer’s Plaques.
STOCKHOLM, Sweden, March 27, 2008. As of today, there is no cure or effective treatment of Alzheimer’s disease. Swedish researchers have now through their discoveries opened up new possible...
